Predictive factors of response to mTOR inhibitors in neuroendocrine tumours

Autor: Zatelli, Maria Chiara, Fanciulli, Giuseppe, Malandrino, Pasqualino, NIKE GROUP: Albertelli M, Arvat E, Baldelli R, Berruti A, Bianchi A, Bodei L, Botti G, Corcione F, Daví MV, Delle Fave G, De Marinis L, Di Sarno A, Dicitore A, Fazio N, Ferolla P, Ferone D, Filice A, Gallo M, Giordano C, Giuffrida D, Guarnotta V, Lania A, Lastoria S, Logoluso F, Loli P, Manzoni M, Marchetti M, Martini C, Messina E, Modica R, Motta C, Papotti M, Partelli S, Persico G, Pia A, Piovesan A, Pontecorvi A, Razzore P, Rota F, Scavuzzo F, Sciammarella C, Vitale G., RAMUNDO, VALERIA, FAGGIANO, ANTONGIULIO, COLAO, ANNAMARIA, DE ROSA, GAETANO
Přispěvatelé: Zatelli, M, Fanciulli, G, Malandrino, P, Ramundo, V, Faggiano, A, Colao, A, Giordano, C, Zatelli, Mc, Nike, Group, Partelli, S, Zatelli, Maria Chiara, Fanciulli, Giuseppe, Malandrino, Pasqualino, Ramundo, Valeria, Faggiano, Antongiulio, Colao, Annamaria, NIKE GROUP: Albertelli, M, Arvat, E, Baldelli, R, Berruti, A, Bianchi, A, Bodei, L, Botti, G, Corcione, F, Daví, Mv, Delle Fave, G, De Marinis, L, DE ROSA, Gaetano, Di Sarno, A, Dicitore, A, Fazio, N, Ferolla, P, Ferone, D, Filice, A, Gallo, M, Giuffrida, D, Guarnotta, V, Lania, A, Lastoria, S, Logoluso, F, Loli, P, Manzoni, M, Marchetti, M, Martini, C, Messina, E, Modica, R, Motta, C, Papotti, M, Persico, G, Pia, A, Piovesan, A, Pontecorvi, A, Razzore, P, Rota, F, Scavuzzo, F, Sciammarella, C, Vitale, G.
Rok vydání: 2015
Předmět:
0301 basic medicine
Oncology
Cancer Research
mTOR inhibitor
Endocrinology
Diabetes and Metabolism

Neuroendocrine tumors
Antineoplastic Agent
0302 clinical medicine
Endocrinology
Neuroendocrine tumours
neuroendocrine tumour
Treatment resistance
MTOR inhibitors
Tumor
Medical treatment
TOR Serine-Threonine Kinases
Discovery and development of mTOR inhibitors
Response to treatment
Patient management
Diabetes and Metabolism
Neuroendocrine Tumors
030220 oncology & carcinogenesis
Neuroendocrine Tumor
Human
Predictors
Animals
Antineoplastic Agents
Biomarkers
Tumor

Diagnostic Imaging
Humans
Protein Kinase Inhibitors
medicine.medical_specialty
Protein Kinase Inhibitor
Early detection
predictor
Biology
NO
03 medical and health sciences
mTOR inhibitors
neuroendocrine tumours
predictors
response to treatment
Internal medicine
medicine
mTOR inhibitors
neuroendocrine tumours
predictors
response to treatment

mTOR inhibitors
neuroendocrine tumours
predictors
response to treatment

Animal
medicine.disease
030104 developmental biology
Immunology
Biomarkers
Resource utilization
Zdroj: Endocrine-Related Cancer. 23:R173-R183
ISSN: 1479-6821
1351-0088
Popis: Medical treatment of neuroendocrine tumours (NETs) has drawn a lot of attention due to the recent demonstration of efficacy of several drugs on progression-free survival, including somatostatin analogs, small tyrosine kinase inhibitors and mTOR inhibitors (or rapalogs). The latter are approved as therapeutic agents in advanced pancreatic NETs and have been demonstrated to be effective in different types of NETs, with variable efficacy due to the development of resistance to treatment. Early detection of patients that may benefit from rapalogs treatment is of paramount importance in order to select the better treatment and avoid ineffective and expensive treatments. Predictive markers for therapeutic response are under intensive investigation, aiming at a tailored patient management and more appropriate resource utilization. This review summarizes the available data on the tissue, circulating and imaging markers that are potentially predictive of rapalog efficacy in NETs.
Databáze: OpenAIRE